OVID
Ovid Therapeutics Inc
NASDAQ: OVID · HEALTHCARE · BIOTECHNOLOGY
$2.69
-0.37% today
Updated 2026-04-29
Market cap
$465.47M
P/E ratio
—
P/S ratio
64.19x
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$0 – $3
Volume
3.4M
Ovid Therapeutics Inc (OVID) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-261281.00 | $-5.49M | $-17.80M | $-31.47M | $-45.56M | $-51.09M | $-51.58M | $118.61M | $-55.23M | $-45.78M | $-55.96M | $-38.33M |
| Capital expenditures | $1783.00 | $56332.00 | $188987.00 | $47387.00 | $352019.00 | $244045.00 | $390680.00 | $184013.00 | $1.42M | $137455.00 | $71000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $33087.00 | $1.46M | $3.64M | $6.40M | $7.06M | $5.21M | $7.53M | $5.05M | $6.56M | $7.29M | $6.28M | $4.81M |
| Free cash flow | $-263064.00 | $-5.54M | $-17.99M | $-31.52M | $-45.91M | $-51.33M | $-51.97M | $118.43M | $-56.65M | $-45.92M | $-56.03M | $-38.33M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $35.19M | $-50.64M | $5.41M | $30.14M | $117.69M | $-142.93M | — | — | — |